Here's the short version. NMN gets into your blood and raises NAD there. That part is solid. The benefits it's sold on, more energy, better muscle, slower aging, haven't held up in human trials so far. A 2026 systematic review of 33 human studies put it plainly: the biology is active, but the clinical payoff is "inconclusive" [1].
What "working" would mean
NMN is meant to raise NAD+, which tends to fall with age; whether raising it improves your health is the open question. In mice, topping up NAD+ helped a long list of age-related problems. People are a different story.
So there are really two questions. Does NMN raise NAD+ in people? And does a higher NAD+ level change anything you'd feel or a doctor could measure? The first has a clear answer. The second doesn't, yet.
Does NMN raise NAD? Yes
Several placebo-controlled trials discussed here reported higher blood NAD or related molecules on NMN. That held across different countries, ages and products.
- In 80 healthy middle-aged adults, blood NAD rose in every NMN group by day 30 and again at day 60, with the biggest rises at the higher amounts tested [2].
- In 30 healthy adults over 12 weeks, whole-blood NAD rose on NMN and not on placebo [3].
- In older men over 6 to 12 weeks, NAD and its breakdown products went up [4].
- In 60 older adults over 12 weeks, blood NAD and its metabolites were higher than on placebo [5].
- A pharmaceutical-grade form called MIB-626 raised blood NAD within 14 days [6].
How fast that happens has its own page: how long NMN takes to work.
Energy and physical performance: mixed
Results on walking and strength were small or secondary, and the main physical-function test often didn't change. That's the pattern across four trials.
- In 60 older adults, the main outcome, a stepping test, didn't differ from placebo at 4 or 12 weeks. A secondary 4-meter walk got faster [5].
- In 80 middle-aged adults, six-minute walk distance rose more than on placebo at days 30 and 60 [2].
- In older men, gait speed and left-hand grip improved only "nominally," and the authors said larger studies are needed [4].
- In 14 older men with diabetes and weak grip or slow walking, 24 weeks of NMN didn't improve grip strength or walking speed [7].
What about energy itself? One 12-week trial of 108 older adults measured fatigue with a questionnaire. Drowsiness improved in some NMN groups, but it also improved in a placebo group, so the change is hard to pin on NMN [8]. These findings do not establish a reliable personal energy benefit.
If energy is what you're after, start with the energy shortlist, which covers options with more behind them.
Blood sugar and metabolism: one positive trial
In 10 weeks, NMN improved muscle insulin sensitivity in women with prediabetes, but a 60-day trial in healthy adults saw no change in insulin resistance.
One positive trial involved a specific population. Postmenopausal women with prediabetes and overweight or obesity took NMN or placebo for 10 weeks. Using a hyperinsulinemic clamp, a detailed physiological measurement, researchers saw muscle take up more glucose in response to insulin on NMN, and not on placebo [9].
The healthy-adult trial measured insulin resistance with a simpler blood score (HOMA-IR). It found no difference from placebo at day 60 [2]. And a small open-label study in 11 men saw lower post-meal insulin in only three of them, with no placebo group to compare against [10].
Body composition and weight: no effect shown
NMN didn't change body composition in the older-men trial [4]. No trial on this page set out to test NMN for weight loss, so there's no evidence it helps there.
Aging and longevity: untested in people
The selected human trials do not establish that NMN slows aging or extends lifespan. Animal longevity findings cannot establish that human benefit.
One trial did report a "blood biological age" score from an online calculator. It rose on placebo and held steady on NMN over 60 days [2]. That's an estimate built from routine lab values, not a measure of how fast someone ages, and it hasn't been repeated.
The 2026 review looked at 33 human studies of NAD precursors. Oral NMN and NR reliably raised NAD-related markers and were well tolerated over weeks to months. Effects on function, metabolism and blood vessels were "heterogeneous and often null" [1].
| Outcome | Result | Trials | Strength of evidence |
|---|---|---|---|
| Blood NAD | Up | Yi 2023; Okabe 2022; Igarashi 2022; Pencina 2023; Morifuji 2024 | Consistent |
| Insulin sensitivity | Up in women with prediabetes; no change in healthy adults | Yoshino 2021; Yi 2023 | Mixed |
| Walking and strength | Small or secondary gains; main tests unchanged | Morifuji 2024; Yi 2023; Igarashi 2022; Akasaka 2023 | Weak |
| Fatigue | Drowsiness improved on NMN and placebo alike | Kim 2022 | Weak |
| Body composition | No change | Igarashi 2022 | Weak (no effect) |
| Sleep quality | Better questionnaire score, a secondary outcome | Morifuji 2024 | Weak |
| Aging and lifespan | Human aging/lifespan benefit not established | Selected short trials do not answer this | Unestablished |
"Weak" means one or two small trials, secondary outcomes, or results that didn't separate from placebo.
Why the trials are hard to read
They're small, short and often run with NMN makers. Most enrolled 30 to 80 people for 12 weeks or less.
- The 60-day trial's first author works for Abinopharm, and two others for Aba Chemicals [2].
- The 12-week walking trial's authors work for Meiji [5].
- Staff of Mitsubishi Corporation Life Sciences co-wrote the older-men trial and supplied the NMN for the 30-person trial [4] [3].
- The MIB-626 study had two co-authors from Metro International Biotech [6].
- In the prediabetes trial, one author held an NMN patent application and another received NMN-related licensing fees [9].
Industry money doesn't make a result wrong. It does mean you'd want outside teams to repeat it, and for most outcomes that hasn't happened yet.
The trials also don't line up neatly. They used different products, different daily amounts and different people, from healthy 30-somethings to men in their 80s with diabetes. Each measured its own mix of outcomes, so a gain in one study rarely gets tested again in the next. That's why a single positive headline tells you less than it seems.
NMN with resveratrol
The cited placebo-controlled trial paired resveratrol with leucine, not NMN; NMN appeared in that paper only in cell and worm experiments [11].
That study does not establish that NMN plus resveratrol works better than NMN alone. If you're weighing NMN against a NAD+ product, see NMN and NAD+ together, and for the other popular precursor, NMN or NR.
Is NMN worth it?
If your goal is a proven effect on energy or aging, not yet; if you want to raise blood NAD, trials show it does that. That's the honest split.
Small trials generally report good short-term tolerability, and you can read the details in is NMN safe. Quality varies by brand, so check our guide to where to buy NMN and whether NMN is legit before you buy. Some people may stop when they do not notice a benefit, and why people stop taking NMN covers that. Your clinician can tell you whether it makes sense alongside anything else you take.